Medical Conditions - Semaglutide

Semaglutide belongs to glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists) and used to treat type 2 diabetes mellitus. By activating GLP-1 receptors, Semaglutide helps lower blood sugar levels in diabetic individuals. It aids in weight loss by reducing appetite and promoting a feeling of fullness. Semaglutide has also been shown to have cardiovascular benefits, including a reduction in the risk of major adverse cardiovascular events in people with established cardiovascular disease. Side effects of Semaglutide include nausea, vomiting, and constipation.